JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB120136

N omega-Nitro-L-arginine methyl ester hydrochloride (L-NAME), NOS inhibitor

Be the first to review this product! Submit a review

|

(10 Publications)

MW 269.69 Da, Purity >98%. Cell-permeable NOS inhibitor. More soluble analog of arginine. (pIC50 values are 4.3, 5.7 and 5.6 at human iNOS, nNOA and eNOS, respectively).
1 Images
Chemical Structure - N omega-Nitro-L-arginine methyl ester hydrochloride (L-NAME), NOS inhibitor (AB120136)
  • Chemical Structure

Lab

Chemical Structure - N omega-Nitro-L-arginine methyl ester hydrochloride (L-NAME), NOS inhibitor (AB120136)

2D chemical structure image of ab120136, N omega-Nitro-L-arginine methyl ester hydrochloride (L-NAME), NOS inhibitor

Key facts

CAS number

51298-62-5

Purity

>98%

Form

Solid

form

Molecular weight

269.69 Da

Molecular formula

C<sub>7</sub>H<sub>1</sub><sub>6</sub>ClN<sub>5</sub>O<sub>4</sub>

PubChem

135193

Nature

Synthetic

Solubility

Soluble in water to 100 mM

Biochemical name

Methyl N5-(imino(nitroamino)methyl)-L-ornithine monohydrochloride

Biological description

Cell-permeable NOS inhibitor. More soluble analog of arginine. (pIC50 values are 4.3, 5.7 and 5.6 at human iNOS, nNOA and eNOS, respectively).

Canonical smiles

COC(=O)C(CCCN=C(N)N[N+](=O)[O-])N.Cl

Isomeric smiles

COC(=O)[C@H](CCCN=C(N)N[N+](=O)[O-])N.Cl

InChi

InChI=1S/C7H15N5O4.ClH/c1-16-6(13)5(8)3-2-4-10-7(9)11-12(14)15;/h5H,2-4,8H2,1H3,(H3,9,10,11);1H/t5-;/m0./s1

InChiKey

QBNXAGZYLSRPJK-JEDNCBNOSA-N

IUPAC Name

methyl (2S)-2-amino-5-[[amino(nitramido)methylidene]amino]pentanoate;hydrochloride

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Storage information
Store under desiccating conditions|The product can be stored for up to 12 months

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The eNOS iNOS and nNOS commonly called endothelial inducible and neuronal nitric oxide synthase respectively play an important role in the production of nitric oxide (NO) from L-arginine. eNOS is typically expressed in endothelial cells iNOS in immune system cells and nNOS in neurons. eNOS has a molecular mass of approximately 133 kDa while iNOS is around 131 kDa and nNOS is about 160 kDa. These enzymes are mainly located in vascular tissues macrophages and nerve tissues. They exhibit distinct expression patterns depending on their cellular environments reflecting their specialized roles in different tissues.
Biological function summary

Nitric oxide synthases produce NO an important signaling molecule that affects vasodilation neurotransmission and microbial killing. eNOS iNOS and nNOS all produce NO but differ in their regulation and temporal expression. eNOS functions constitutively and is calcium-calmodulin dependent. In contrast iNOS is calcium-independent and gets induced under inflammatory conditions. nNOS also operates constitutively and modulates neuronal communication. While these enzymes do not form a multimeric complex themselves they often associate with other proteins to exert their functions effectively.

Pathways

Nitric oxide synthases significantly contribute to the nitric oxide signaling pathway. In this context eNOS is pivotal in the regulation of blood pressure and flow by modulating vascular tone. It interacts with calmodulin and other enzymes like phosphoinositide 3-kinase (PI3K) in endothelial cells. nNOS in the nervous system participates in synaptic plasticity and interacts with proteins such as NMDA receptors to influence learning and memory pathways. iNOS meanwhile becomes highly active in immune response pathways particularly involving macrophages where NO acts as a defense mechanism against pathogens.

Abnormal nNOS activity links to neurodegenerative conditions like Alzheimer's disease. nNOS through excessive NO production can lead to neuronal damage. In cardiovascular disorders eNOS dysfunction associates with hypertension and atherosclerosis due to impaired NO-mediated vasodilation. Here eNOS's interaction with proteins like caveolin-1 may alter its functionality. Both the abnormal activities of nNOS and eNOS highlight their importance in maintaining physiological health and how their dysregulation can contribute to disease pathology.

Product protocols

Publications (10)

Recent publications for all applications. Explore the full list and refine your search

Frontiers in oncology 12:976961 PubMed36052260

2022

Erythropoietin receptor regulates tumor mitochondrial biogenesis through iNOS and pAKT.

Applications

Unspecified application

Species

Unspecified reactive species

Mostafa A Aboouf,Franco Guscetti,Nadine von Büren,Julia Armbruster,Hyrije Ademi,Maja Ruetten,Florinda Meléndez-Rodríguez,Thomas Rülicke,Alexander Seymer,Robert A Jacobs,Edith M Schneider Gasser,Julian Aragones,Drorit Neumann,Max Gassmann,Markus Thiersch

Basic research in cardiology 116:66 PubMed34940922

2021

Increased protein S-nitrosylation in mitochondria: a key mechanism of exercise-induced cardioprotection.

Applications

Unspecified application

Species

Unspecified reactive species

Doria Boulghobra,Mathilde Dubois,Béatrice Alpha-Bazin,Florence Coste,Maxime Olmos,Sandrine Gayrard,Isabelle Bornard,Gregory Meyer,Jean-Charles Gaillard,Jean Armengaud,Cyril Reboul

Frontiers in psychiatry 11:837 PubMed33088274

2020

Repeated Nitrous Oxide Exposure Exerts Antidepressant-Like Effects Through Neuronal Nitric Oxide Synthase Activation in the Medial Prefrontal Cortex.

Applications

Unspecified application

Species

Unspecified reactive species

Wei Liu,Qian Li,Binglu Ye,Hang Cao,Fuyi Shen,Zhendong Xu,Weijia Du,Fei Guo,Jinqi Liu,Tianyu Li,Bing Zhang,Zhiqiang Liu

Bone 135:115305 PubMed32126313

2020

Skeletal restoration by phosphodiesterase 5 inhibitors in osteopenic mice: Evidence of osteoanabolic and osteoangiogenic effects of the drugs.

Applications

Unspecified application

Species

Unspecified reactive species

Subhashis Pal,Mamunur Rashid,Sandeep Kumar Singh,Konica Porwal,Priya Singh,Riyazuddin Mohamed,Jiaur R Gayen,Muhammad Wahajuddin,Naibedya Chattopadhyay

Archives of oral biology 101:108-121 PubMed30927660

2019

Chondrocyte apoptosis in rat mandibular condyles induced by dental occlusion due to mitochondrial damage caused by nitric oxide.

Applications

Unspecified application

Species

Unspecified reactive species

Haotian Ren,Hongxu Yang,Mianjiao Xie,Yi Wen,Qian Liu,Xiaomei Li,Jun Liu,Haokun Xu,Weizhong Tang,Meiqing Wang

Proceedings of the National Academy of Sciences of 115:E6900-E6909 PubMed29967172

2018

Molecular profiling of reticular gigantocellularis neurons indicates that eNOS modulates environmentally dependent levels of arousal.

Applications

Unspecified application

Species

Unspecified reactive species

Inna Tabansky,Yupu Liang,Maya Frankfurt,Martin A Daniels,Matthew Harrigan,Sarah Stern,Teresa A Milner,Rebecca Leshan,Rrezarta Rama,Tabea Moll,Jeffrey M Friedman,Joel N H Stern,Donald W Pfaff

Cell reports 21:1009-1020 PubMed29069584

2017

Dendritic Cell Amiloride-Sensitive Channels Mediate Sodium-Induced Inflammation and Hypertension.

Applications

Unspecified application

Species

Unspecified reactive species

Natalia R Barbaro,Jason D Foss,Dmytro O Kryshtal,Nikita Tsyba,Shivani Kumaresan,Liang Xiao,Raymond L Mernaugh,Hana A Itani,Roxana Loperena,Wei Chen,Sergey Dikalov,Jens M Titze,Bjorn C Knollmann,David G Harrison,Annet Kirabo

International journal of molecular sciences 18: PubMed28757565

2017

The Pharmaceutical Device Prisma Skin Promotes in Vitro Angiogenesis through Endothelial to Mesenchymal Transition during Skin Wound Healing.

Applications

Unspecified application

Species

Unspecified reactive species

Raffaella Belvedere,Valentina Bizzarro,Luca Parente,Francesco Petrella,Antonello Petrella

BMC research notes 7:230 PubMed24721461

2014

Infection of human monocytes by Chlamydia pneumoniae and Chlamydia trachomatis: an in vitro comparative study.

Applications

Unspecified application

Species

Unspecified reactive species

Antonella Marangoni,Christian Bergamini,Romana Fato,Claudia Cavallini,Manuela Donati,Paola Nardini,Claudio Foschi,Roberto Cevenini

Journal of neurophysiology 111:659-74 PubMed24259545

2013

Nitric oxide-mediated modulation of the murine locomotor network.

Applications

Unspecified application

Species

Unspecified reactive species

Joshua D Foster,Catherine Dunford,Keith T Sillar,Gareth B Miles
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com